Potentiation of Antibiotics by a Novel Antimicrobial Peptide against Shiga Toxin Producing E. coli O157:H7
Abstract Infection with Shiga toxin-producing Escherichia coli (STEC) results in hemorrhagic colitis and can lead to life-threatening sequelae including hemolytic uremic syndrome (HUS). Conventional treatment is intravenous fluid volume expansion. Antibiotic treatment is contraindicated, due in part...
Guardado en:
Autores principales: | Juan Puño-Sarmiento, Erin M. Anderson, Amber J. Park, Cezar M. Khursigara, Debora E. Barnett Foster |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0edb1c5c948142bd894bb0fce1d656c6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Genomic analysis of Shiga toxin-producing Escherichia coli O157:H7 from cattle and pork-production related environments
por: Peipei Zhang, et al.
Publicado: (2021) -
Population structure and genetic diversity of non-O157 Shiga toxin-producing Escherichia coli (STEC) clinical isolates from Michigan
por: Heather M. Blankenship, et al.
Publicado: (2021) -
Identification, Shiga toxin subtypes and prevalence of minor serogroups of Shiga toxin-producing Escherichia coli in feedlot cattle feces
por: Kaylen M. Capps, et al.
Publicado: (2021) -
Genomic, proteomic and physiological characterization of a T5-like bacteriophage for control of Shiga toxin-producing Escherichia coli O157:H7.
por: Yan D Niu, et al.
Publicado: (2012) -
Publisher Correction: Genomic analysis of Shiga toxin-producing Escherichia coli O157:H7 from cattle and pork-production related environments
por: Peipei Zhang, et al.
Publicado: (2021)